Chief Financial Officer (CFO) Ole Larsen Buys Shares

2024-03-13
临床结果临床2期IPO
KØBENHAVN, DK / ACCESSWIRE / March 13, 2024 / FluoGuide A/S (STO:FLUO) Copenhagen, Denmark - 13 March 2024 - FluoGuide A/S ("FluoGuide" or the "Company") today announces that Ole Larsen (CFO) has bought shares. Member of the Executive Management Ole Larsen has bought 529 shares in the Company at an average share price of SEK 54.364. After the buy, Ole holds 3,000 shares in the Company. The Company has published strong results from phase II trials demonstrating the efficacy of FG001 as well as showing it was well tolerated and safe from clinical trials in patients undergoing surgery to remove aggressive brain (high-grade glioma), head & neck and lung cancers. Based on this strong foundation, FluoGuide expands the scope of application of FG001 and advance the development toward approval in aggressive brain cancer. FluoGuide is listed on Nasdaq First North Growth Market, Stockholm under the ticker "FLUO". Read more about FluoGuide's pipeline, technology, and upcoming events on Attachments Chief Financial Officer (CFO) Ole Larsen buys shares Notification to Danish FSA SOURCE: FluoGuide A/S View the original press release on accesswire.com
更多内容,请访问原始网站
文中所述内容并不反映新药情报库及其所属公司任何意见及观点,如有版权侵扰或错误之处,请及时联系我们,我们会在24小时内配合处理。
靶点
-
药物
来和芽仔聊天吧
立即开始免费试用!
智慧芽新药情报库是智慧芽专为生命科学人士构建的基于AI的创新药情报平台,助您全方位提升您的研发与决策效率。
立即开始数据试用!
智慧芽新药库数据也通过智慧芽数据服务平台,以API或者数据包形式对外开放,助您更加充分利用智慧芽新药情报信息。